Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 13-Dec-12 3:55 PM View:  | Altschul Arthur G Jr Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 8,497 | $44.00 | $373,868.00 | (100%) 8.5K to 0 | |
| 13-Dec-12 4:59 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 203,990 | $44.00 | $8,975,560.00 | (100%) 204.71K to 0.72K | |
| 13-Dec-12 4:20 PM View: | Knight Peter S Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 12,532 | $44.00 | $551,408.00 | (100%) 12.53K to 0 | |
| 13-Dec-12 4:35 PM View: | Shackelford Lottie H Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 10,422 | $44.00 | $458,568.00 | (100%) 10.42K to 0 | |
| 13-Dec-12 4:10 PM View: | Davidson Spencer Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 9,722 | $44.00 | $427,768.00 | (100%) 9.72K to 0 | |
| 13-Dec-12 9:00 PM View: | Hanson Jason David EVP,COO | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 225,513 | $44.00 | $9,922,570.00 | (100%) 225.51K to 0 | |
| 13-Dec-12 5:00 PM View: | Ippolito Vincent P EVP, Sales & Marketing | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 187,590 | $44.00 | $8,253,960.00 | (100%) 187.59K to 0 | |
| 13-Dec-12 4:59 PM View: | Peterson Richard D EVP, CFO & Corp Treasurer | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 205,889 | $44.00 | $9,059,120.00 | (100%) 205.99K to 0.1K | |
| 13-Dec-12 3:57 PM View: | Altschul Arthur G Jr Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition Duplicate | 8,497 | $44.00 | $373,868.00 | (100%) 8.5K to 0 | |
| 13-Dec-12 4:59 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 718 | $44.00 | $31,592.00 | (100%) 0.72K to 0 | |
| 13-Dec-12 4:45 PM View: | Prygocki Mark A Sr President | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 301,613 | $44.00 | $13,271,000.00 | (100%) 302.17K to 0.55K | |
| 13-Dec-12 5:00 PM View: | Rodner Seth L EVP, CLO & Corp Secretary | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 53,792 | $44.00 | $2,366,850.00 | (100%) 53.79K to 0 | |
| 13-Dec-12 4:15 PM View: | Diamond Stuart Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 8,675 | $44.00 | $381,686.00 | (100%) 8.67K to 0 | |
| 13-Dec-12 4:30 PM View: | Schein Philip S Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 8,222 | $44.00 | $361,768.00 | (100%) 8.22K to 0 | |
| 13-Dec-12 4:25 PM View: | Pietrangelo Michael Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 15,920 | $44.00 | $700,480.00 | (100%) 15.92K to 0 | |
| 13-Dec-12 4:40 PM View: | Shacknai Jonah CEO Director | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 928,825 | $44.00 | $40,868,300.00 | (100%) 928.83K to 0 | |
| 13-Dec-12 4:59 PM View: | Peterson Richard D EVP, CFO & Corp Treasurer | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 102 | $44.00 | $4,488.00 | (100%) 0.1K to 0 | |
| 13-Dec-12 4:45 PM View: | Prygocki Mark A Sr President | Medicis Pharmaceutical Corp. (MRX) | 11-Dec-12 | Disposition | 552 | $44.00 | $24,288.00 | (100%) 0.55K to 0 | |
| 13-Dec-12 4:45 PM View: | Prygocki Mark A Sr President | Medicis Pharmaceutical Corp. (MRX) | 07-Dec-12 | Gift | 2,300 | -- | -- | (< 1%) 304.46K to 302.17K | |
| 13-Dec-12 4:59 PM View: | Peterson Richard D EVP, CFO & Corp Treasurer | Medicis Pharmaceutical Corp. (MRX) | 06-Dec-12 | Gift | 2,300 | -- | -- | (1%) 208.29K to 205.99K | |
| 13-Dec-12 4:25 PM View: | Pietrangelo Michael Director | Medicis Pharmaceutical Corp. (MRX) | 30-Nov-12 | Gift | 2,000 | -- | -- | (11%) 17.92K to 15.92K | |
| 27-Nov-12 7:00 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 26-Nov-12 | Option Exercise | 154,500 | $33.56 | $5,185,640.00 | 76% 203.99K to 358.49K | |
| 27-Nov-12 7:00 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 26-Nov-12 | Market Option Sale (Planned) | 154,500 | $43.24 | $6,681,350.00 | (43%) 358.49K to 203.99K | (< 1%) |
| 14-Nov-12 6:48 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 12-Nov-12 | Market Sale (Planned) Duplicate | 11,668 | $42.35 | $494,112.00 | (5%) 215.66K to 203.99K | (< 1%) |
| 14-Nov-12 6:48 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 12-Nov-12 | Market Sale (Planned) | 11,668 | $42.35 | $494,112.00 | (5%) 215.66K to 203.99K | (< 1%) |
| 14-Nov-12 9:40 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 12-Nov-12 | Market Sale (Planned) Duplicate | 11,668 | $42.35 | $494,112.00 | (5%) 215.66K to 203.99K | (< 1%) |
| 14-Nov-12 6:48 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 12-Nov-12 | Market Sale (Planned) Duplicate | 11,668 | $42.35 | $494,112.00 | (5%) 215.66K to 203.99K | (< 1%) |
| 02-Nov-12 6:15 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 31-Oct-12 | Market Sale (Planned) | 11,500 | $43.35 | $498,468.00 | (5%) 227.16K to 215.66K | (< 1%) |
| 02-Nov-12 6:15 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 31-Oct-12 | Gift | 10,000 | -- | -- | (4%) 237.16K to 227.16K | |
| 17-Oct-12 6:25 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 15-Oct-12 | Market Sale (Planned) | 11,500 | $43.39 | $499,025.00 | (5%) 248.66K to 237.16K | (< 1%) |
| 02-Oct-12 6:10 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 01-Oct-12 | Market Sale (Planned) | 11,500 | $43.27 | $497,658.00 | (4%) 260.16K to 248.66K | < 1% |
| 18-Sep-12 5:00 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 17-Sep-12 | Market Sale (Planned) | 11,500 | $43.49 | $500,165.00 | (4%) 271.66K to 260.16K | < 1% |
| 18-Sep-12 5:00 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 29-Aug-12 | Gift | 2,000 | $32.30 | $64,600.00 | (< 1%) 273.66K to 271.66K | (35%) |
| 28-Aug-12 6:30 PM View: | Shackelford Lottie H Director | Medicis Pharmaceutical Corp. (MRX) | 24-Aug-12 | Market Option Sale | 20,000 | $32.53 | $650,670.00 | (66%) 30.42K to 10.42K | (< 1%) |
| 28-Aug-12 6:30 PM View: | Shackelford Lottie H Director | Medicis Pharmaceutical Corp. (MRX) | 24-Aug-12 | Option Exercise | 21,000 | $20.44 | $429,240.00 | 223% 9.42K to 30.42K | |
| 27-Aug-12 5:40 PM View: | Knight Peter S Director | Medicis Pharmaceutical Corp. (MRX) | 23-Aug-12 | Option Exercise | 3,500 | $20.44 | $71,540.00 | 28% 12.53K to 16.03K | |
| 27-Aug-12 5:40 PM View: | Knight Peter S Director | Medicis Pharmaceutical Corp. (MRX) | 23-Aug-12 | Market Option Sale | 3,500 | $32.16 | $112,560.00 | (22%) 16.03K to 12.53K | < 1% |
| 27-Aug-12 5:35 PM View: | Pietrangelo Michael Director | Medicis Pharmaceutical Corp. (MRX) | 23-Aug-12 | Market Option Sale | 21,000 | $32.17 | $675,639.00 | (54%) 38.92K to 17.92K | < 1% |
| 27-Aug-12 5:35 PM View: | Pietrangelo Michael Director | Medicis Pharmaceutical Corp. (MRX) | 23-Aug-12 | Option Exercise | 21,000 | $20.44 | $429,240.00 | 117% 17.92K to 38.92K | |
| 22-Aug-12 6:00 PM View: | Diamond Stuart Director | Medicis Pharmaceutical Corp. (MRX) | 20-Aug-12 | Market Option Sale | 17,500 | $32.76 | $573,318.00 | (67%) 26.18K to 8.68K | 2% |
| 22-Aug-12 6:00 PM View: | Diamond Stuart Director | Medicis Pharmaceutical Corp. (MRX) | 20-Aug-12 | Option Exercise | 17,500 | $22.40 | $392,000.00 | 202% 8.68K to 26.18K | |
| 17-Aug-12 7:05 PM View: | Peterson Richard D EVP, CFO & Corp Treasurer | Medicis Pharmaceutical Corp. (MRX) | 17-Aug-12 | Market Sale | 11,000 | $32.87 | $361,517.00 | (5%) 228.19K to 217.19K | < 1% |
| 20-Aug-12 8:00 PM View: | Hanson Jason David EVP,COO | Medicis Pharmaceutical Corp. (MRX) | 17-Aug-12 | Market Sale | 43,496 | $33.02 | $1,436,050.00 | (16%) 269.01K to 225.51K | (< 1%) |
| 20-Aug-12 7:55 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 17-Aug-12 | Market Sale | 20,000 | $32.97 | $659,416.00 | (7%) 293.66K to 273.66K | (< 1%) |
| 05-Jul-12 7:05 PM View: | Shacknai Jonah CEO Director | Medicis Pharmaceutical Corp. (MRX) | 03-Jul-12 | Payment of Exercise | 3,948 | $34.79 | $137,351.00 | (< 1%) 945.27K to 941.33K | 0% |
| 05-Jul-12 7:05 PM View: | Shacknai Jonah CEO Director | Medicis Pharmaceutical Corp. (MRX) | 03-Jul-12 | Option Exercise | 5,456 | $18.33 | $100,008.00 | < 1% 939.82K to 945.27K | |
| 05-Jun-12 7:05 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 04-Jun-12 | Option Exercise | 5,456 | $18.33 | $100,008.00 | 2% 292.14K to 297.6K | |
| 05-Jun-12 7:05 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 04-Jun-12 | Payment of Exercise | 3,939 | $34.98 | $137,786.00 | (1%) 297.6K to 293.66K | 0% |
| 29-May-12 7:10 PM View: | Wortzman Mitchell S EVP | Medicis Pharmaceutical Corp. (MRX) | 25-May-12 | Payment of Exercise | 40,604 | $36.93 | $1,499,510.00 | (12%) 332.75K to 292.14K | 0% |
| 29-May-12 7:05 PM View: | Shacknai Jonah CEO Director | Medicis Pharmaceutical Corp. (MRX) | 25-May-12 | Payment of Exercise | 193,722 | $36.93 | $7,154,150.00 | (17%) 1.13M to 939.82K | 0% |
